RESUMO
INTRODUCTION: Premature rupture of membranes remains a challenge for professionals due to the high rates of maternal and neonatal morbidity and mortality, mainly related to complications resulting from prematurity. OBJECTIVE: To analyze the scientific production about premature rupture of membranes in pregnancies above 28 weeks and below 34 weeks. METHODS: Integrative literature review carried out in the Lilacs, SciELO, Medline and Cochrane Library databases, between 2014 and 2018, in Portuguese, English and Spanish, including original articles, available in full online, with free access, that addressed the study theme, using the keywords "premature rupture of ovular membranes", "premature labor" and "pregnancy complications" combined using the Boolean operators "AND" and "OR". RESULTS: Fourteen studies were included. It was possible to highlight the main recommendations regarding preterm premature rupture of membranes, divided into six categories for discussion, namely: indications for expectant management and delivery induction, prophylactic antibiotic therapy, prenatal corticosteroids, use of tocolytics, recommendations regarding the use of magnesium sulfate and amniocentesis. CONCLUSION: It was identified that expectant management is the ideal approach, with constant monitoring of the pregnant woman and the fetus, in addition to the administration of prophylactic antibiotics and prenatal corticosteroids, in the face of premature rupture of membranes in pregnancies between 28 and 34 weeks in order to provide the best maternal and perinatal results, guiding health professionals to evidence-based practice.
INTRODUÇÃO: A ruptura prematura de membranas continua a ser um desafio para os profissionais devido às altas taxas de morbimortalidade materna e neonatal, relacionada principalmente às complicações decorrentes da prematuridade. OBJETIVO: Analisar a produção científica acerca das evidências frente a ruptura prematura de membranas em gestações acima de 28 semanas e abaixo de 34 semanas. MÉTODOS: Revisão integrativa da literatura realizada nas bases de dados Lilacs, SciELO, Medline e Cochrane Library, entre 2014-2018, em português, inglês e espanhol, incluídos artigos originais, disponíveis completos online, com acesso livre, que abordassem a temática do estudo, utilizando os descritores "ruptura prematura de membranas ovulares", "trabalho de parto prematuro" e "complicações na gravidez" combinados por meio dos operadores booleanos "AND" e "OR". RESULTADOS: Foram incluídos 14 estudos, nos quais foi possível evidenciar as principais recomendações frente a ruptura prematura de membranas fetais pré-termo, divididos em seis categorias para discussão, sendo elas: indicações para o manejo expectante e indução do parto, antibioticoterapia profilática, corticosteroides pré-natais, uso de tocoliÌticos, recomendações quanto ao uso de sulfato de magnésio e realização de amniocentese. CONCLUSÃO: O estudo possibilitou identificar que o manejo expectante é a conduta ideal, com monitorização constante da gestante e do feto, além da administração de antibióticos profiláticos e corticosteroides pré-natais, frente a ruptura prematura de membranas em gestações entre 28 e 34 semanas a fim de proporcionar os melhores resultados maternos e perinatais, guiando os profissionais da saúde para uma prática baseada em evidências.
Assuntos
Humanos , Feminino , Gravidez , Ruptura Prematura de Membranas Fetais , Trabalho de Parto Prematuro , Tocólise , Corticosteroides , Antibioticoprofilaxia , Conduta Expectante , Amniocentese , Trabalho de Parto Induzido , Sulfato de MagnésioRESUMO
O sulfato de magnésio tem sido utilizado em obstetrícia por décadas e milhares de mulheres já foram incluídas em ensaios clínicos que estudaram sua eficácia em uma variedade de condições gestacionais. Os principais usos do medicamento na atual prática obstétrica incluem prevenção e tratamento de convulsões eclâmpticas, prolongamento da gravidez para administração antenatal de corticosteroides e neuroproteção fetal na iminência de interrupção prematura da gravidez. Em função da alta qualidade e da consistência dos resultados de importantes ensaios clínicos, a indicação do sulfato de magnésio para profilaxia e terapia das convulsões eclâmpticas está bem estabelecida. Entretanto, tal unanimidade não ocorre com relação ao seu emprego como tocolítico, tanto pela discussão sobre sua efetividade quanto pelas doses mais altas usualmente utilizadas para esse fim. Em relação à importância do sulfato de magnésio como agente neuroprotetor fetal, a paralisia cerebral é a causa mais comum de deficiência motora na infância e tem como fator de risco mais importante a prematuridade, cuja incidência tem aumentado significativamente. Diretrizes nacionais e internacionais mais recentes, baseadas em resultados de ensaios clínicos randomizados e metanálises de boa qualidade, mostraram que a administração antenatal de sulfato de magnésio na iminência de parto pré-termo precoce é uma intervenção eficiente, viável, segura, com boa relação custo-benefício e pode contribuir para a melhoria dos desfechos neurológicos neonatais.
Magnesium sulfate has been used in obstetrics for decades and thousands of women have already been included in clinical trials that have studied its effectiveness in a variety of gestational conditions. The main uses of the drug in current obstetrical practice include prevention and treatment of eclamptic seizures, prolongation of pregnancy for antenatal administration of corticosteroids, and fetal neuroprotection in the imminence of premature termination of pregnancy. Because of the high quality and consistency of the results of important clinical trials, the indication of magnesium sulfate for prophylaxis and therapy of eclamptic seizures is well established. However, such unanimity does not occur regarding its use as tocolytic, either by the discussion of its effectiveness or by the higher doses usually used for this purpose. Regarding the importance of magnesium sulfate as a fetal neuroprotective agent, cerebral palsy is the most common cause of motor deficits in childhood and has a significantly higher incidence of prematurity as a major risk factor. More recent national and international guidelines, based on results from randomized controlled trials and good quality meta-analyzes, have shown that the antenatal administration of magnesium sulfate at the imminence of early preterm delivery is a cost-effective, viable, efficient intervention and safe and can contribute to the improvement of neonatal neurological outcomes.
Assuntos
Humanos , Feminino , Gravidez , Sulfato de Magnésio/uso terapêutico , Obstetrícia , Tocólise , Paralisia Cerebral , Eclampsia/tratamento farmacológico , Neuroproteção , Trabalho de Parto Prematuro , MagnésioRESUMO
INTRODUCCIÓN: Se presenta el caso de un parto diferido en una gestación gemelar en la que se consigue retrasar el parto del segundo gemelo 45 días con manejo conservador. CASO CLÍNICO: Mujer de 25 años, gestación gemelar bicorial biamniótica, con diagnóstico de muerte fetal del primer gemelo en semana 24+3 y parto del mismo tras una semana de evolución. Se decide la opción de tratamiento conservador expectante, con reposo absoluto, manteniendo tocolisis intravenosa, controles analíticos seriados, controles cardiotocográficos diarios, profilaxis antibiótica y antitrombótica. Con ello se consigue diferir el parto un total de 45 días. CONCLUSIÓN: El parto diferido en gestaciones gemelares es una práctica poco habitual, por lo que se carece de protocolos y actuaciones específicas. La bibliografía disponible difiere en cuanto al manejo de dichos casos y en el total de días que se consigue diferir el parto, pero en todos los estudios se reporta el beneficio en términos de resultados perinatales al conseguir aumentar la edad gestacional del segundo gemelo. En nuestro caso se consiguió una mejora sustancial del resultado perinatal asociado a la prematuridad sin importantes efectos adversos maternos y tras el periodo de latencia indicado.
INTRODUCTION: We report a delayed delivery of a dichorionic diamniotic twin pregnancy, in which the birth of the second twin was postponed 45 days. CASE REPORT: At 24+3 weeks of gestation, a 25-year-old woman with dichorionic diamniotic twin pregnancy presented with preterm premature rupture of membranes and intrauterine dead of the first fetus. Spontaneous delivery of the first death twin, occurred al 25+2 weeks. Tocolysis, antibiotic, antithrombotic prophylaxis, absolute rest, serial blood tests and fetal cardiotocography controls, were performed. The second twin was delivered at 31+5 weeks, after a the preterm premature rupture of membranes triggered the labor. The interval between the first and second birth was 45 days. CONCLUSION: Delayed delivery in twin pregnancies, is an uncommon clinical situation, so there are not validated medical protocols. Available bibliography offers different practices related to its management. Most studies confirm the better survival rate and perinatal outcomes of the postponed birth twin.
Assuntos
Humanos , Feminino , Gravidez , Adulto , Trabalho de Parto Prematuro/terapia , Gravidez Múltipla , Fatores de Tempo , Tocólise , Morte Fetal , Conduta Expectante , Tratamento ConservadorRESUMO
Abstract Objectives: to evaluate the effects of nifedipine with tocolysis under maternal and fetal parameters. Methods: a cohort study with 40 pregnant women admitted at a high-risk pregnancy ward to inhibit premature labor between September/2010 to May/2012. Nifedipine was used as a 20mg sublingual attack dose and maintained 20mg every six and eight hours orally. The variables of the analysis were fetal heart rate (FHR), maternal heart rate (MHR), systolic blood pressure (SBP) and diastolic blood pressure (DBP), and amniotic fluid index (AFI). All the variables were evaluated prior to administrating nifedipine and approximately after 6 hours and every 24 hours, until hospital discharge. Results: there were no modification of the FHR (p=0.48) and the SBP (p=0.29). The MHR increased after 24 hours, but with no statistical difference (p=0.08), returning to similar levels as at admission within 48 hours. The DBP decreased at 6 (p=0.04) to 72 hours, being stable afterwards. The AFI decreased significantly at 24, 48 and 72 hours. Conclusions: the use of high doses of nifedipine with tocolysis causes a decrease of the maternal's diastolic blood pressure and consequently decreases the amniotic fluid index, but probably without any clinical repercussions.
Resumo Objetivos: avaliar os efeitos da nifedipina utilizada na tocólise sobre os parâmetros maternos e fetais. Métodos: estudo de coorte incluindo 40 gestantes admitidas na enfermaria de alto risco para inibição do trabalho de parto prematuro entre setembro/2010 a maio/2012. Utilizou-se a nifedipina sublingual na dose de ataque de 20mg e uma manutenção de 20mg por via oral a cada seis e oito horas. As variáveis avaliadas foram os batimentos cardio-fetais (BCF), frequência cardíaca materna (FCM), pressão arterial sistólica (PAS) e diastólica (PAD) e índice de líquido amniótico (ILA). Todas as variáveis foram avaliadas antes da administração da nifedipina e aproximadamente após 6h e cada 24h até alta hospitalar. Resultados: não houve modificação dos BCF (p=0,48) e da PAS (p=0,29). A FCM aumentou após 24h, mas sem significância estatística (p=0,08) retornando a níveis similares ao da admissão com 48h. A PAD diminuiua partir de 6h (p = 0,04)até 72h, mantendo-se constante. O ILA diminuiu significativamente em 24h, 48h e 72h. Conclusão: a utilização de altas doses de nifedipina para tocóliseocasio na diminuição dos níveis pressóricos diastólicos maternos e consequentemente diminuição do ILA, mas provavelmente sem repercussões clínicas.
Assuntos
Humanos , Feminino , Gravidez , Nifedipino/administração & dosagem , Tocólise/métodos , Ultrassonografia Pré-Natal , Líquido Amniótico/diagnóstico por imagem , Trabalho de Parto Prematuro , Estudos de Coortes , Gravidez de Alto RiscoRESUMO
PURPOSE: To analyze and compare the clinical factors and neurodevelopmental outcomes compare early- and late-onset periventricular leukomalacia (PVL) in very low birth weight infants (VLBWI). METHODS: We performed a retrospective study involving 199 newborn infants weighing < 1,500 g admitted to the neonatal intensive care unit between March 2009 and December 2015. VLBWI with PVL were categorized into early- and late-onset PVL groups based on the time of diagnosis based on 28 days of age. We analyzed the clinical factors and neurodevelopmental outcomes between the groups. RESULTS: The incidence rate of PVL was 10.1% (16/158). The Apgar score at 1 minute and the mean duration of tocolytic therapy were associated with the development of PVL. The incidence rate of premature rupture of membranes (PROM) was significantly higher in the early-onset PVL group (P=0.041). No significant differences were observed in neurodevelopmental outcomes between the early- and late-onset PVL groups. CONCLUSION: Results suggest that a higher incidence of PROM was associated with clinical characteristics in the early-onset PVL group. No significant intergroup differences were observed in neurodevelopmental outcomes; however, the Bayley Scales of Infant Development-III scores were lower in the early-onset PVL group.
Assuntos
Feminino , Humanos , Lactente , Recém-Nascido , Gravidez , Índice de Apgar , Diagnóstico , Ruptura Prematura de Membranas Fetais , Incidência , Recém-Nascido de muito Baixo Peso , Terapia Intensiva Neonatal , Leucomalácia Periventricular , Membranas , Estudos Retrospectivos , Ruptura , Tocólise , Pesos e MedidasRESUMO
Abstract Objective To evaluate the use of tocolysis in cases of preterm birth due to spontaneous preterm labor in a Brazilian sample. Methods A sample of 1,491 women with preterm birth due to spontaneous preterm labor were assessed, considering treatment with tocolysis or expectant management, according to gestational age at birth (< 34 weeks and 34 to 36 þ 6 weeks) and drugs prescribed. The study took place in 20 Brazilian hospitals from April 2011 to July 2012. Bivariate analyses were conducted to evaluate associations with sociodemographic and obstetric characteristics and odds ratios with their respective 95% confidence intervals were estimated for maternal and neonatal outcomes. Results A total of 1,491 cases of preterm birth were considered. Tocolysis was performed in 342 cases (23%), 233 of which (68.1%) were delivered before 34 weeks. Within the expectant management group, 73% was late preterm and with more advanced labor at the time of admission. The most used drugs were calcium channel blockers (62.3%), followed by betamimetics (33%). Among the subjects in the tocolysis group, there were more neonatal and maternal complications (majority non-severe) and an occurrence of corticosteroid use that was 29 higher than in the expectant management group. Conclusion Tocolysis is favored in cases of earlier labor and also among thosewith less than 34 weeks of gestation, using preferably calcium channel blockers, with success in achieving increased corticosteroid use. Tocolysis, in general, was related to higher maternal and neonatal complication rates, which may be due to the baseline difference between cases at admission. However, these results should raise awareness to tocolysis use.
Resumo Objetivo: Avaliar o uso da tocólise em partos prematuros decorrentes de trabalho de parto espontâneo numa amostra brasileira. Métodos Um total de 1.491 mulheres com parto prematuro decorrente de trabalho de parto espontâneo foram avaliadas, considerando a realização de tocólise ou conduta expectante, de acordo com a idade gestacional ao nascimento (< 34 semanas e 34 a 36 þ 6 semanas) e com as drogas prescritas. O estudo ocorreu em 20 hospitais brasileiros, de abril de 2011a julho de 2012. Análises bivariadas foram realizadas para avaliar associações com características sociodemográficas e obstétricas. Foram calculadas as relações de probabilidade comseus respectivos intervalos de confiança (95%) para os desfechos neonatais e maternos. Resultados Um total de 1.491 casos de partos prematuros foram considerados, e a tocólise foi realizada em 342 (23%) casos, dos quais 233 (68,1%) tiveram partos antes das 34 semanas. No grupo da conduta expectante, 73% forampré-termos tardios e com trabalho de parto mais avançado à admissão. As drogas mais utilizadas foram os bloqueadores do canal de cálcio (62.3%), seguidos pelos betamiméticos (33%). No grupo da tocólise houvemais complicações neonatais ematernas (maioria não grave) e um uso de corticosteroides 29 vezes mais frequente que nos casos de conduta expectante. Conclusão A tocólise foi mais favorável nos casos de trabalho de parto inicial e nos partos realizados antes de 34 semanas de gestação, usando preferencialmente bloqueadores do canal de cálcio, comsucesso em realizar altas taxas de corticoterapia. A tocólise esteve associada a maiores taxas de complicações maternas e neonatais, o que pode ser explicado pela diferença basal dos casos à admissão. Entretanto, esses resultados devem acender um alerta em relação ao uso de tocolíticos.
Assuntos
Humanos , Feminino , Gravidez , Adulto , Adulto Jovem , Tocólise , Nascimento Prematuro/prevenção & controle , Brasil , Estudos Transversais , Resultado do TratamentoRESUMO
OBJECTIVE: In terms of efficacy, several previous studies have shown that the success rate in inhibiting preterm labor was not different between magnesium sulfate and ritodrine. However, there is a paucity of information regarding the efficacy of both medications after consideration of intra-amniotic infection, which is one of the most important prognostic factors in patients of threatened preterm birth. The objective of this study was to compare the efficacy and safety of magnesium sulfate with that of ritodrine in preterm labor. METHODS: In this retrospective cohort study, we included patients who were admitted and treated with either ritodrine or magnesium sulfate with the diagnosis of preterm labor at 24–33.6 weeks of gestational age between January 2005 to April 2015. Patients were divided into 2 groups according to the first-used tocolytics (ritodrine group and magnesium sulfate group). We compared the efficacy and prevalence of side effect in each group. The efficacy of both tocolytics was evaluated in terms of preterm delivery within 48 hours, 7 days, or 37 weeks of gestation and need for 2nd line therapy. RESULTS: A total number of 201 patients were enrolled including 177 cases in ritodrine group and 24 cases in magnesium sulfate group. The efficacy of both tocolytics (preterm delivery within 48 hours, 7 days, or 37 weeks of gestation and need for 2nd line therapy) was not different between the 2 groups of cases. In multivariate analysis, gestational age at treatment, twin gestation, intra-amniotic infection and maternal C-reactive protein (CRP) was associated with treatment failure (preterm delivery within 48 hours), but the type of tocolytics was not significantly associated with treatment failure. The type of side effect was different in the 2 groups, but the frequency of total adverse effect, need for discontinuation of therapy because of maternal adverse effect, and severe adverse effect were not different between the two groups of cases. CONCLUSION: The efficacy and safety of magnesium sulfate was similar to ritodrine, and can be a substitute tocolytics. Additionally, failure of tocolytic therapy was determined by gestational age at treatment, twin gestation, intra-amniotic infection, and maternal CRP, not by the type of tocolytics.
Assuntos
Feminino , Humanos , Gravidez , Proteína C-Reativa , Estudos de Coortes , Diagnóstico , Idade Gestacional , Sulfato de Magnésio , Magnésio , Análise Multivariada , Trabalho de Parto Prematuro , Nascimento Prematuro , Prevalência , Estudos Retrospectivos , Ritodrina , Tocólise , Tocolíticos , Falha de Tratamento , GêmeosRESUMO
Este trabajo trata de la actualización del uso de ATOSIBAN para el tratamiento de la amenaza de parto prematuro, utilizando para su aplicación el protocolo de administración de Tractocile en el servicio de partes vs internado general, a los efectos de sistematizar los cuidados de enfermería en la utilización de este medicamento.
Assuntos
Humanos , Feminino , Gravidez , Trabalho de Parto Prematuro , Tocólise , Tocolíticos/administração & dosagemRESUMO
O parto prematuro é um dos maiores desafios obstétricos na atualidade, apresentando altas taxas de morbimortalidade perinatal. O presente capítulo foi elaborado com o objetivo de uniformizar condutas para o diagnóstico e manejo terapêutico do trabalho de parto prematuro.
Preterm birth is a major obstetrical challenges nowadays, presenting high rates of perinatal morbidity and mortality. This chapter has been elaborated with the objective of standardize practices for the diagnosis and therapeutic management of preterm labor.
Assuntos
Trabalho de Parto Prematuro/diagnóstico , Trabalho de Parto Prematuro/tratamento farmacológico , Tocólise , Corticosteroides , TocolíticosRESUMO
BACKGROUND: The consequences of preterm birth not only for the baby but also for the mother has been well documented over the years. Numerous interventions have been tried and tested and yet it is still a significant problem to date. Progesterone has been documented to be an effective prophylactic drug against preterm labor for those considered at high risk for developing the condition. However, little is known its effectiveness when given in oral form as a maintenance tocolysis for those who already suffered from an acute episode or preterm labor.OBJECTIVE:To evaluate the effectiveness of oral progesterone in the prevention of preterm birth after being diagnosed of preterm laborDESIGN: Meta-analysisSUBJECTS: The study population consisted of women with singleton gestation who were diagnosed with preterm labor, defined as having contractions associated with corresponding cervical dilatation, which were treated with oral progesterone as a maintenance tocolytic until delivery.DATA COLLECTION: Journals were searched in different journal databases. Reviewers independently assessed the eligibility of the articles included in this study. Methodologic quality was reviewed using the Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). Data extracted were analysed using the Review Manager 5.3 Software (Revman 2014) and the Comprehensive Meta-Analysis Software (CMA3 2016).RESULTS: No statistical difference was noted in terms of latency prolongation, gestational age at birth, occurrence of preterm birth, and on neonatal outcomes such as APGAR Score CONCLUSION: The use of oral progesterone as a maintenance tocolysis after arrested preterm labor showed no statistically significant benefit except for higher birthweight in babies upon delivery.
Assuntos
Humanos , Feminino , Tocólise , Tocolíticos , Idade Gestacional , Nascimento Prematuro , Progesterona , Morte Perinatal , Trabalho de Parto Prematuro , Peso ao Nascer , Parto ObstétricoRESUMO
El parto pretérmino representa un reto terapéutico ya que su tratamiento oportuno disminuye la morbilidad y mortalidad \r\nneonatal. Afecta de 5 a 11% de todos los partos en el mundo, entre 9 y 10% en países de bajos ingresos y de 6 a 11,9% en países \r\ncon altos ingresos. Es el responsable de 70% de las muertes neonatales y 37% de las muertes en infantes así como el causante de \r\n25 a 50% de los casos de falla en el desarrollo neurológico en niños. Por lo anterior, es importante realizar un adecuado tamizaje \r\ny tratamiento de las pacientes que se encuentran en riesgo de parto pretérmino. Para ello, se realizó una guía fármacoterapeutica \r\nbasada en la mejor evidencia para su manejo.
preterm labor represents a therapeutic challenge because \r\nopportune treatment decreases neonatal morbidity and \r\nmortality. It affects 5-11% of all worldwide births. Of these \r\nbirths 9-10% occurred in low-income countries and 6-11.9% in \r\nhigh-income countries. Preterm labor is responsible for 70% \r\nof neonatal deaths and 37% of infant deaths; it causes 25-50% \r\nof the cases of neurological development failure in children. \r\nBecause of this, it is important to perform adequate screening \r\nand treatment of patients at risk for preterm delivery. A pharma\r\n-\r\nceutical guide based on the best evidence for its management \r\nwas performed.
O parto prematuro representa um desafio terapêutico, uma vez \r\nque seu tratamento oportuno diminui a morbidez e mortali\r\n-\r\ndade neonatal. Afeta de 5 a 11% de todos os partos no mundo, \r\nsendo que, entre 9 e 10% ocorrem em países de baixa renda, \r\ne de 6 a 11,9%, em países de alta renda. É responsável por 70% \r\ndas mortes neonatais e 37% das mortes em recém-nascidos, \r\nassim como é o causador de 25 a 50% dos casos de falha no \r\ndesenvolvimento neurológico em crianças. Por este motivo, \r\né importante realizar uma triagem e tratamento adequados \r\ndas pacientes que se encontram em risco de parto prematuro. \r\nPortanto, foi elaborado um guia farmacoterapêutico com base \r\nna melhor evidência para seu manuseio.
Assuntos
Progesterona , Esteroides , Tocólise , Parto , Trabalho de Parto Prematuro , MagnésioRESUMO
OBJECTIVE: This study aimed to examine clinical practice patterns in the management of pregnant women admitted with threatened preterm labor (TPL) in Korea. METHODS: Data from women admitted with a diagnosis of TPL were collected from 22 hospitals. TPL was defined as regular uterine contractions with or without other symptoms such as pelvic pressure, backache, increased vaginal discharge, menstrual-like cramps, bleeding/show and cervical changes. Data on general patient information, clinical characteristics at admission, use of tocolytics, antibiotics, and corticosteroids, and pregnancy outcomes were collected using an online data collections system. RESULTS: A total of 947 women with TPL were enrolled. First-line tocolysis was administered to 822 (86.8%) patients. As a first-line tocolysis, beta-agonists were used most frequently (510/822, 62.0%), followed by magnesium sulfate (183/822, 22.3%), calcium channel blockers (91/822, 11.1%), and atosiban (38/822, 4.6%). Of the 822 women with first-line tocolysis, second-line tocolysis were required in 364 (44.3%). Of 364 with second-line, 199 had third-line tocolysis (37.4%). Antibiotics were administered to 29.9% of patients (284/947) with single (215, 22.7%), dual (26, 2.7%), and triple combinations (43, 4.5%). Corticosteroids were administered to 420 (44.4%) patients. Betamethasone was administered to 298 patients (71.0%), and dexamethasone was administered to 122 patients (29.0%). CONCLUSION: Practice patterns in the management of TPL in Korea were quite various. It is needed to develop standardized practice guidelines for TPL management.
Assuntos
Feminino , Humanos , Gravidez , Corticosteroides , Antibacterianos , Dor nas Costas , Betametasona , Bloqueadores dos Canais de Cálcio , Dexametasona , Diagnóstico , Coreia (Geográfico) , Sulfato de Magnésio , Cãibra Muscular , Trabalho de Parto Prematuro , Padrões de Prática Médica , Resultado da Gravidez , Gestantes , Nascimento Prematuro , Estudos Retrospectivos , Tocólise , Tocolíticos , Contração Uterina , Descarga VaginalRESUMO
Preterm birth (PTB) remains a major cause of neonatal mortality and morbidity, despite improvements in tocolytic treatment and neonatal care. Progesterone (17a-hydroxyprogesterone) produced naturally or synthetically can prevent PTB when applied vaginally and orally. Progesterone use may be a safe and cost-effective option in cases of singleton pregnancy with prior PTB, asymptomatically short cervix and arrested preterm labor.
Assuntos
Feminino , Humanos , Lactente , Gravidez , Colo do Útero , Mortalidade Infantil , Trabalho de Parto Prematuro , Nascimento Prematuro , Progesterona , TocóliseRESUMO
To determine the effectiveness of transdermal patch of glyceryl trinitrate as tocolytic agent. Interventional- Quasi experimental study. Department of Obstetrics and Gynecology Unit- 1, Services hospital, Lahore. One year [February 10, 2006 - February 10, 2007]. Fifty pregnant women with preterm labour were included in the study. 54% of pregnant women were between G2 - G4. Majority [48%] of the women presented between 31 - 34 weeks of gestation. 46% of pregnant women had bishop score of 4 or more. 64% of patients found to have no risk factor for preterm labour. Majority [86%] responded after application of second patch [10 mg glyceryl trinitrate patch]. 84% had no side effects. Local skin reaction [10%] and headache [4%] observed in few patients. 58% of pregnant women delivered after 48 hours and 78% of them delivered vaginally which was statically significant and majority of babies delivered weight more than 1.5 kg and with good Apgar score. It is concluded from the study that glyceryl trinitrate is a safer tocolytic, which has simple method of application; rapid onset of action with low cost, low risk from side effects and it does not require intensive monitoring
Assuntos
Humanos , Feminino , Nitroglicerina , Tocólise , Gravidez , Adesivo Transdérmico , Nitroglicerina/administração & dosagemRESUMO
Objetivo: Analizar la morbimortalidad en pretérminos extremos evaluando la influencia de factores obstétricos. Método: Estudio retrospectivo de 132 casos nacidos entre las semanas 23 y 27 en el Hospital La Paz, desde 2003 a 2005. Se establecieron tres grupos obstétricos: Amenaza de Parto Pretérmino, Rotura Prematura de Membranas y la asociación de ambas. Se evaluaron como variables obstétricas: tocolisis, corticoterapia, motivo de finalización de la gestación y vía de parto, y como variables en niños: mortalidad y morbilidad respiratoria, neurológica, visual y auditiva en neonatos y a los dos años. Resultados: Los casos con amenaza de parto pretérmino presentaron mayor displasia broncopulmonar y ductus arterioso persistente que los otros dos grupos obstétricos (p=0,03). Las pacientes con amenaza de parto pretérmino y tocolisis desarrollaron menos hemorragia intraventricular [36,4 por ciento (12/33)] e infarto periventricular (0 por ciento) que los casos sin tocolisis, en los que aparecieron en el 68,4 por ciento (13/19) y 31,6 por ciento(6/19), respectivamente (p=0,03 y p=0,001). Además en este subgrupo, los casos que recibieron corticoterapia desarrollaron menos infarto periventricular (0 por ciento) y parálisis cerebral a los 2 años [6,7 por ciento (2/30)], que los que no la recibieron, en los que apareció un 40 por ciento (6/15) de infarto y un 40 por ciento (4/10) de parálisis cerebral, respectivamente (p=0,0001 y p=0,02). La hemorragia intraventricular y la parálisis cerebral fueron más frecuentes en partos vaginales de casos con amenaza de parto pretérmino que en cesáreas [63,3 por ciento (19/30) y 26,1 por ciento (6/23) frente a 27,3 por ciento (6/22) y 0 por ciento; p=0,01 y 0,03]. Conclusión: La conducta obstétrica puede modificar el pronóstico neonatal y a los 2 años de seguimiento.
Objective: Analyse morbidity and mortality in extreme preterm at birth and at 2 year follow-up evaluating the influence of obstetrical factors. Methods: Retrospective study of 132 cases born between weeks 23 and 27 at La Paz Hospital from 2003 to 2005. Three obstetrical groups were established: Threat of Preterm Birth, Premature Rupture of Membranes and the combination of both. The following were evaluated as obstetrical variables: tocolysis, corticosteroid therapy and type of delivery. As variables in children: mortality and respiratory, neurological, visual and auditive morbidity in neonates and two years of age. Results: In the cases of threat of preterm birth a greater bronchopulmonary dysplasia and persistent ductus arteriosus appeared than in the other two obstetrical groups (p=0.03). Focusing on the threat of birth group, the cases with maternal tocolysis developed fewer neurological complications, intraventricular hemorrhage of 36.4 percent (12/33) and periventricular infarct of 0 percent, whereas the cases without tocolysis showed 68.4 percent (13/19) and 31.6 percent (6/19) respectively (p=0.03, p=0.001). Also in this subgroup, the cases that received corticosteroid therapy developed less periventricular infarct (0 percent) and cerebral palsy at age 2 [6.7 percent (2/30)] than the ones that did not receive it in which the percentages were 40 percent (6/15) and 40 percent (4/10) (p=0.0001 and p=0.02 respectively). Also, intraventricular hemorrhage and cerebral palsy were more frequent in vaginal delivery than in caesarean sections in this subgroup [63.3 percent (19/30) and 26.1 percent (6/23) against 27.3 percent (6/22) and 0 percent; p=0.01 and p=0.03)]. Conclusion: Obstetrical characteristics and behaviour can have a decisive impact in the neonatal outcome and after two-year follow-up.
Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Complicações na Gravidez/terapia , Doenças do Prematuro/etiologia , Doenças do Prematuro/mortalidade , Doenças do Prematuro/prevenção & controle , Cesárea , Espanha/epidemiologia , Esteroides/uso terapêutico , Seguimentos , Idade Gestacional , Morbidade , Nascimento Prematuro/prevenção & controle , Assistência Perinatal , Prognóstico , Estudos Retrospectivos , Ruptura Prematura de Membranas Fetais/prevenção & controle , Tocólise , Trabalho de Parto Prematuro/prevenção & controleRESUMO
Comparar la eficacia del clorhidrato de isoxuprina o la nifedipina en la tocólisis de la amenaza de parto pretérmino. Se seleccionaron 82 pacientes con edad gestacional entre 24 y 34 semanas y diagnóstico de amenaza de parto pretérmino. Las pacientes se dividieron al azar en 2 grupos para recibir clorhidrato de isoxuprina (grupo A) o nifedipina (grupo B). Se determinaron el tiempo de cese de las contracciones, tensión arterial materna, concentraciones de glucosa y efectos adversos maternos. Maternidad "Dr. Nerio Belloso", Hospital Central "Dr. Urquinaona", Maracaibo. Estado Zulia. Se logró una tocólisis efectiva en las primeras 24 horas en 61,0 por ciento y 70,7 por ciento de las pacientes del grupo A y B, respectivamente (P = ns). Después de 7 días de tratamiento, 36,6 por ciento de las pacientes en el grupo A y 31,7 por ciento de las pacientes en el grupo B aun permanecían sin contracciones (P = ns). Se logró un retraso del parto hasta las 34 semanas o más en 26,8 por ciento y 29,3 por ciento de las pacientes de los grupos A y B, respectivamente. En el grupo de pacientes tratadas con clorhidrato de isoxuprina se observó un aumento significativo de las concentraciones séricas de glucosa (P < 0,001). Los efectos adversos maternos fueron significativamente más frecuentes en el grupo de clorhidrato de isoxuprina después de 2 y 24 horas de tratamiento (P < 0,05). La nifedipina es igual de efectiva que el clorhidrato de isoxuprina en la tocólisis de la amenaza de parto pretérmino y produce menos efectos adversos
To compare the efficacy of isoxuprine clorhidrate or nifedipine in tocolysis of threatened preterm labor. 82 patients with a gestational age between 24 and 34 weeks and threatened preterm labor diagnosis were selected. Patients were randomly divided in 2 groups to receive isoxuprine clorhidrate (group A) or nifedipine (group B). Time of cease of contractions, maternal blood pressure, glucose concentrations and maternal adverse effects were determined. Maternidad "Dr. Nerio Belloso", Hospital Central "Dr. Urquinaona", Maracaibo. Estado Zulia. An effective tocolysis was obtained within 24 hours in 61.0 percent and 70.7 percent for patients in group A and B, respectively (P = ns). After 7 days of treatment, 36.6 percent of patients in group A and 31,7 percent of patients in group B were still without contractions (P = ns). A delay in labor till 34 weeks or more was made in 26.8. percent and 29.3 percent of patients in group A and B, respectively. In the group of patients treated with isoxuprine clorhidrate a significant raise of glucose concentrations was observed (P < 0.001). Maternal adverse effects were significant more frequent in isoxuprine clorhidrate group after 2 and 24 hours of treatment (P < 0,05). Nifedipine has a similar effectivity than isoxuprine clorhidrate for tocolysis in threatened preterm labor and produces less adverse effects
Assuntos
Humanos , Feminino , Gravidez , Guanidina/efeitos adversos , Isoxsuprina/efeitos adversos , Nifedipino/efeitos adversos , Tocólise/efeitos adversos , Tocólise/métodos , Trabalho de Parto Prematuro , Cuidado Pré-NatalRESUMO
Preterm labour is a major healthcare problem throughout the world; it is a major cause of perinatal morbidity and mortality, that is not significantly altered by the current drug therapies, most of which are associated with significant maternal or fetal side effects. To evaluate the role of human chorionic gonadotrophin [HCG] in the treatement of preterm labour. Fifty-seven women with preterm labour were enrolled in this clinical trial at Al-Yarmouk Teaching Hospital/department of Obstetrics and Gynaecology - Baghdad/Iraq during the period from April, 1st 2006 till November, 30th 2006, and were assigned to receive a single intramuscular injection of 5000 units of HCG followed by a drip of 10000 units of HCG in 500 ml 5% dextrose over 6 hours. 30 women continued the study and the mean prolongation of the pregnancy was calculated for all of them. The mean prolongation of pregnancy was 32.97 +/- 17.6 days and it was highest among gestational ages of 29.30 weeks [43.3% +/- 19.85 days], with the mean gestational age at birth was 35.7 +/- 2.8 weeks. All babies born to these women had weight appropriate for their gestational age at birth with a mean birth weight of 2.7 +/- 0.64 kg and 60% of babies weighed > 2.5 kg at birth. It was shown through this trial that human chorionic gonadotropin was effective in exhibiting potent tocolysis and prolonging pregnancy in preterm labour without causing adverse effects to the mothers or their babies. This can make a major contribution to the management of this common obstetrical complication
Assuntos
Humanos , Feminino , Trabalho de Parto Prematuro/tratamento farmacológico , Hospitais de Ensino , Tocólise , GravidezRESUMO
O presente estudo é uma pesquisa qualitativa exploratório-descritiva, cujo objetivo foi compreender a vivência de mulheres durante a inibição de trabalho de parto pré-termo no centro obstétrico. Os dados foram coletados pormeio de entrevistas semiestruturadas com seis puérperas, no alojamento conjunto de uma maternidade deFlorianópolis - SC, de agosto a outubro de 2008, e analisados de acordo com a proposta do Discurso do Sujeito Coletivo. As ideias centrais e os discursos contemplam aspectos sobre os efeitos colaterais do uso de drogas uteroinibidoras, orientação recebida dos profissionais, sentimentos vivenciados, apoio emocional, cuidados recebidos e desconfortos referidos. Os efeitos colaterais dos fármacos uteroinibidores repercutiram em sentimentos de ambivalência entre a necessidade de continuar inibindo e o desejo de que a criança nascesselogo; contudo, após a decisão clínica da interrupção da inibição, surgiram sentimentos de alívio. A assistência àmulher durante a inibição do trabalho de parto deve valorizar os aspectos emocionais, assim como osdesconfortos decorrentes do tratamento instituído.
During the inhibition of preterm labor at the obstetric center. Data were collected through semi-structuredinterviews with six postpartum mothers at a maternity room in Florianopolis, SC, from August to October 2008.They were reviewed in accordance with the proposal of Collective Subject's Discourse. The Central Ideas andDiscourses include the following aspects: side effects of drug uterus-inhibitors, orientation received fromprofessionals, experienced feelings, emotional support, care received and distress reported. The side effects ofdrugs uterus-inhibitor influenced on feelings of ambivalence between the need to continue inhibiting and thedesire of childbirth. However, after the discontinuation of clinical decision of inhibition, feelings of relief emerged.Assistance to women during the inhibition of preterm labor might value the emotional aspects as well as thedistress resulting from the treatment.
Inhibición de trabajo de parto pretérmino en el centro obstétrico. Los datos fueron recogidos a través deentrevistas semiestructuradas con seis puérperas, en el alojamiento conjunto de una maternidad deFlorianópolis-SC, de agosto a octubre de 2008, y analizados de acuerdo con la propuesta del Discurso del SujetoColectivo. Las Ideas Centrales y los Discursos contemplan aspectos sobre los efectos colaterales del uso dedrogas útero-inhibidoras, orientación recibida de los profesionales, sentimientos vivenciados, apoyo emocional,cuidados recibidos e incomodidades referidas. Los efectos colaterales de los fármacos útero-inhibidoresrepercutieron en sentimientos de ambivalencia entre la necesidad de continuar inhibiendo y el deseo que el bebénaciese pronto. Con todo, después de la decisión clínica de la interrupción de la inhibición, surgieronsentimientos de alivio. La asistencia a la mujer durante la inhibición del trabajo de parto debe valorizar losaspectos emocionales, así como las incomodidades decurrentes del tratamiento instituido.
Assuntos
Humanos , Feminino , Enfermagem Obstétrica , Pesquisa Qualitativa , Tocólise , Trabalho de Parto PrematuroRESUMO
OBJETIVO: comparar a efetividade da nitroglicerina transdérmica com a nifedipina oral na inibição do trabalho de parto prematuro. MÉTODOS: foi realizado um ensaio clínico com 50 mulheres em trabalho de parto prematuro, randomizadas em dois grupos, 24 para nifedipina oral (20 mg) e 26 para nitroglicerina transdérmica (patch 10 mg). Foram selecionadas as pacientes com gestação única, entre a 24ª e 34ª semanas e diagnóstico de trabalho de parto prematuro. Foram excluídas pacientes com malformações fetais e com doenças clínicas ou obstétricas. As variáveis analisadas foram tocólise efetiva, tempo necessário para tocólise, frequência de recorrência, progressão para parto prematuro e efeitos colaterais. RESULTADOS: a eficácia da tocólise nas primeiras 12 horas foi semelhante entre os grupos (nitroglicerina: 84,6 por cento versus nifedipina: 87,5 por cento; p=0,5). A média do tempo para tocólise também foi semelhante (6,6 versus 5,8 horas; p=0,3). Não houve diferença entre os grupos quanto à recorrência de parto prematuro (26,9 versus 16,7 por cento; p=0,3) e nem na frequência de parto prematuro dentro de 48 horas (15,4 versus 12,5 por cento; p=0,5). Entretanto, a frequência de cefaleia foi significativamente maior no grupo que usou nitroglicerina (30,8 versus 8,3 por cento; p=0,04). CONCLUSÕES: a nitroglicerina transdérmica apresentou efetividade semelhante à nifedipina oral para inibição do trabalho de parto prematuro nas primeiras 48 horas, porém com maior frequência de cefaleia.
PURPOSE: to compare the effectiveness of transdermal nitroglycerin with oral nifedipine in the inhibition of preterm delivery. METHODS: a clinical essay has been performed with 50 women in preterm delivery, randomly divided into two groups, 24 receiving oral nifedipine (20 mg), and 26, transdermal nitroglycerin (10 mg patch). Patients with a single gestation, between the 24th and the 34th weeks and diagnosis of preterm delivery were selected. Women with fetal malformation and clinical or obstetric diseases were excluded. The variables analyzed were: effective tocolysis, time needed for tocolysis, recurrence frequency, progression to preterm delivery, and side effects. RESULTS: tocolysis efficacy in the first 12 hours was similar between the groups (nitroglycerin: 84.6 percent versus nifedipine: 87.5 percent; p=0.50). The time average time needed for tocolysis was also similar (6.6 versus 5.8 hours; p=0.30). There was no difference between the groups, concerning the recurrence of preterm delivery (26.9 versus 16.7 percent; p=0.30), and neither in the rate of preterm delivery within 48 hours (15.4 versus 12.5 percent; p=0.50). Nevertheless, the cephalea rate was significantly higher in the Nitroglycerin Group (30.8 versus 8.3 percent; p=0.04). CONCLUSIONS: transdermal nitroglycerin has presented similar effectiveness to oral nifedipine to inhibit preterm delivery in the first 48 hours, however with higher cephalea frequency.
Assuntos
Adolescente , Adulto , Feminino , Humanos , Gravidez , Adulto Jovem , Nifedipino/administração & dosagem , Nitroglicerina/administração & dosagem , Tocólise , Tocolíticos/administração & dosagem , Vasodilatadores/administração & dosagem , Administração Cutânea , Administração Oral , Adulto JovemRESUMO
El trabajo de parto es un evento de riesgo para hipoxia fetal aguda, lo que puede detectarse en alteraciones del Monitoreo Electrónico Fetal Intraparto (MEFI). Frente a un MEFI sugerente de hipoxemia fetal, existen maniobras estándar de resucitación intrauterina como lateralización de la paciente, aporte de volumen intravenoso y suspensión de la infusión oxitócica. Se debate la utilidad de la hiperoxigenación materna y la tocolisis aguda. Revisamos la evidencia científica relevante sobre la utilidad y seguridad de estas dos maniobras. Encontramos sólo limitada evidencia respecto del efecto benéfico de la hiperoxigenación materna frente a alteraciones del MEFI, existiendo dudas de su inocuidad. La tocolisis aguda ha demostrado ser eficaz en lograr la normalización del MEFI, independiente de la presencia de hiperactividad uterina, con una efectividad cercana al 80 por ciento. La evidencia apoya el uso de B-miméticos y Nitroglicerina. Recomendamos incluir en la practica clínica habitual la tocolisis aguda y la hiperoxigenación materna sólo por lapsos breves, junto a las maniobras habituales de resucitación intrauterina frente a un MEFI alterado. (
Labor is a risk condition for acute fetal hypoxia, this hypoxia can be detected by using cardiotocography (CTG). When CTG suggest hypoxia, intrauterine resuscitation techniques must be implemented, such as lateral positioning of the mother, intravenous fluid administration and suspension of oxytocin administration. Among intrauterine resuscitation techniques it is discussed the use of maternal hyperoxygenation and acute tocolysis. Here we review the evidence supporting utility and safety of these two techniques. We found only limited evidence supporting the beneficial role of maternal hyperoxygenation after nonreassuring CTG, plus concerns about its safety. Acute tocolysis has proven to be efficient in normalizing CTG, independent of the presence of uterine hyperactivity, with an overall benefit of 80 percent. Evidence supports the use of B-mimetics and nitroglycerin. We recommend to include acute tocolysis and maternal hyperoxygenation (just for limited time), among intrauterine resuscitation techniques for abnormal CTG.